Houman takes on a question he says many men on Ozempic, Wegovy and Mounjaro ask him. The clip pushes a comment-for-guide offer.
Recap by typeshit. Post by @justin.houman.md on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A look at how regulators are handling the surge in peptide use, from approved medicines like insulin and GLP-1 drugs to the wider market.
Newsweek points to research showing patients can put lost weight back on quickly once they come off GLP-1 drugs.
Loading…